Renalytix Ai Stock Revenue
| RNLX Stock | USD 0.13 0.02 13.33% |
Renalytix AI fundamentals help investors to digest information that contributes to Renalytix's financial success or failures. It also enables traders to predict the movement of Renalytix Stock. The fundamental analysis module provides a way to measure Renalytix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Renalytix stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 2.3 M | 1.9 M |
Renalytix | Revenue |
Renalytix AI Company Revenue Analysis
Renalytix's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Renalytix Revenue | 2.29 M |
Most of Renalytix's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Renalytix AI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Renalytix
Projected quarterly revenue analysis of Renalytix AI provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Renalytix match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Renalytix's stock price.
Renalytix Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Renalytix is extremely important. It helps to project a fair market value of Renalytix Stock properly, considering its historical fundamentals such as Revenue. Since Renalytix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Renalytix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Renalytix's interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Renalytix Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Renalytix AI reported 2.29 M of revenue. This is 99.97% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 99.98% higher than that of the company.
Renalytix Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Renalytix's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Renalytix could also be used in its relative valuation, which is a method of valuing Renalytix by comparing valuation metrics of similar companies.Renalytix is currently under evaluation in revenue category among its peers.
Renalytix Institutional Holders
Institutional Holdings refers to the ownership stake in Renalytix that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Renalytix's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Renalytix's value.| Shares | Cvi Holdings Llc | 2024-06-30 | 38.3 K | Xtx Topco Ltd | 2024-09-30 | 20.2 K | Lpl Financial Corp | 2024-09-30 | 18.4 K | Baader Bank Inc | 2024-09-30 | 15 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 14.5 K | Virtu Financial Llc | 2024-06-30 | 12.5 K | Ironwood Investment Counsel, Llc | 2024-09-30 | 12 K | Cim, Llc | 2024-06-30 | 12 K | Jane Street Group Llc | 2024-06-30 | 11.9 K | Pinnacle Associates Inc | 2024-09-30 | 846.5 K | Easterly Investment Partners. | 2024-09-30 | 555 K |
Renalytix Fundamentals
| Return On Equity | -10.73 | ||||
| Return On Asset | -0.94 | ||||
| Operating Margin | (9.43) % | ||||
| Current Valuation | 33.51 M | ||||
| Shares Outstanding | 82.96 M | ||||
| Shares Owned By Insiders | 4.51 % | ||||
| Shares Owned By Institutions | 4.13 % | ||||
| Number Of Shares Shorted | 378.92 K | ||||
| Price To Book | 18.77 X | ||||
| Price To Sales | 9.85 X | ||||
| Revenue | 2.29 M | ||||
| Gross Profit | 720 K | ||||
| EBITDA | (28.52 M) | ||||
| Net Income | (33.46 M) | ||||
| Cash And Equivalents | 32.36 M | ||||
| Cash Per Share | 0.89 X | ||||
| Total Debt | 8.54 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | (0.05) X | ||||
| Cash Flow From Operations | (30.11 M) | ||||
| Short Ratio | 0.39 X | ||||
| Earnings Per Share | (0.62) X | ||||
| Target Price | 2.5 | ||||
| Beta | 2.1 | ||||
| Market Capitalization | 22.55 M | ||||
| Total Asset | 7.97 M | ||||
| Retained Earnings | (211.78 M) | ||||
| Working Capital | 12.2 M | ||||
| Net Asset | 7.97 M |
About Renalytix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Renalytix AI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Renalytix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Renalytix AI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Renalytix Stock Analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.